Briefing: Lack of FDA Advisory Committees Raises Concerns

Strategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse.

by Editorial Staff|Mar 9, 2026|1 MIN READ|WORLD

Summary

  • FDA is reportedly shunning advisory committees.
  • Concerns from drugmakers, patients, and doctors.
  • Potential implications for drug approval processes.

Key Facts

Fact Value
Source STAT
Published Date March 9, 2026

Sources